A large amount of data suggests that 5-LOX inhibitors may be more effective than 12-LOX inhibitors in preventing the growth of cancer cells in the kidney because the specific relationship of the 5-LOX pathway is more closely related to carcinogenesis than that of the 12-LOX pathway (Matsuyama et al., 2004). This evidence concerns the gene ALOX5 and cancer.